Emunin (NZ71), a glycine amide conjugate of emetine, also displays non-toxicity while reduces the expression of HSP70 and HSP27, and significantly increases the sensitivity of myeloma and prostate carcinoma cells to inhibitors of proteasome and HSP90 (Table 1) 170. The gene discussed is HSPB1; the disease is plasma cell myeloma.